Results 191 to 200 of about 154,929 (213)

Myokines in cancer: bridging molecular mechanisms to biomarker discovery and therapeutic innovation. [PDF]

Front Oncol
Zhang H, Fu D, Yue M, Cheng F, Jiang Y, Zhao J, Wang W, Deng S, Tian D, Jin G, Li Q.   +10 more
europepmc   +1 more source

Cucurbitacin B Promotes Tumor Necrosis Factor Receptor 1 Ectodomain Shedding by Selectively Activating the Extracellular Signal-Regulated Kinase Signaling Pathway. [PDF]

Int J Mol Sci
Yarangsee P, Fukai I, Phol S, Kinugawa K, Kusagawa E, Miyake Y, Kataoka T.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Efficacy of tumor necrosis factor inhibitors in hand osteoarthritis: A systematic review and meta-analysis of randomized controlled trials

Osteoarthritis and Cartilage Open, 2023
Mahnuma Mahfuz Estee, Flavia M Cicuttini, Matthew J Page   +2 more
exaly  

Tumor Necrosis Factor-α and Insulin Induce Plasminogen Activator Inhibitor Type-1 in Adipocytes

Journal of the American College of Cardiology, 1998
openaire   +1 more source

Cycling of tumor necrosis factor inhibitors versus switching to different mechanism of action therapy in rheumatoid arthritis patients with inadequate response to tumor necrosis factor inhibitors: a Bayesian network meta-analysis

Therapeutic Advances in Musculoskeletal Disease, 2021
Alberto Migliore, Giuseppe Pompilio, Joe Zhuo   +2 more
exaly  

The Comparative Safety of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: A Meta-analysis Update of 44 Trials

American Journal of Medicine, 2014
Tzeyu L Michaud, Young Hee Rho, Tatyana A Shamliyan   +2 more
exaly  

<p>Effect of tumor necrosis factor inhibitors on interstitial lung disease in rheumatoid arthritis: angel or demon?</p>

Drug Design, Development and Therapy, 2019
Weiji Lin, Zhe Chen, Yu Wang
exaly  

Tumor necrosis factor inhibitors in psoriatic arthritis

Expert Review of Clinical Pharmacology, 2017
Alexis Ogdie, Walter K Kraft
exaly  

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α Inhibitors

Clinical Infectious Diseases, 2009
April C Pettit, Patty W Wright, Mark J Mulligan   +2 more
exaly